Document is current

Article History

Received: 20 May 2024

Accepted: 4 September 2024

First Online: 16 September 2024

Declarations

:

: Approval for this study was granted by the institutional review boards (IRBs) of the Noguchi Memorial Institute for Medical Research (NMIMR) (approval number: NMIMR-IRB CPN 016/20–21) and the Naval Medical Research Command, Maryland (approval number: NAMRU-PJT-20-02). Eligible patients were made to provide a written informed consent before enrollment.

: Not applicable.

: The authors declare no conflict of interest. Some authors are military service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C., § 105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C., § 101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties. The funders had no role in the study’s design, in the collection, analyses, or interpretation of data, in writing the manuscript, or in the decision to publish the results.

: The views expressed in this article reflect the results of research conducted by the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, the U.S. Government, nor the institutions affiliated with the authors. Financial support for this study was from the Armed Forces Health Surveillance Division (AFHSD), Global Emerging Infections Surveillance (GEIS) Branch (funding year 2021, ProMIS ID P115_21_N3).